Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The First Case of Eruptive Pyogenic Granuloma Following Covid-19 Vaccination Publisher



Alzahawi S1 ; Ghanadan A2 ; Saberi F1 ; Balighi K1, 3 ; Razavi Z1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran
  2. 2. Department of Dermatopathology, Razi Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran
  3. 3. Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Case Reports in Dermatology Published:2024


Abstract

Introduction: Pyogenic granuloma presents clinically as a rapidly growing, friable, red papule of skin or mucosa, commonly measuring less than 10 mm with frequent bleeding due to ulceration. Angioproliferative diseases including pyogenic granuloma and cherry angioma have been reported during COVID-19 infection or following COVID-19 vaccination. Case Presentation: Here, we report a 52-year-old female patient who developed diffuse skin eruptions 3 weeks after the second dose of COVID-19 vaccination. Conclusion: As per our knowledge, this is the first case of eruptive PG following COVID- 19 vaccination. Oral propranolol and PDL laser therapy were administered after obtaining inconvenient results from electro-cautery, and there was a good response within 6 weeks of starting therapy, defined by the cessation of new lesion formation and a decrease in the size of large lesions. © 2024 The Author(s). Published by S. Karger AG, Basel.
Related Docs
1. A Systematic Review of Histopathologic Surveys on Mucocutaneous Biopsies in Patients Developed Covid-19 Vaccine-Related Dermatologic Manifestations, American Journal of Dermatopathology (2023)